99 related articles for article (PubMed ID: 11814851)
1. Non-natural glycosphingolipids and structurally simpler analogues bind HIV-1 recombinant Gp120.
McReynolds KD; Bhat A; Conboy JC; Saavedra SS; Gervay-Hague J
Bioorg Med Chem; 2002 Mar; 10(3):625-37. PubMed ID: 11814851
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurements of recombinant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers.
Conboy JC; McReynolds KD; Gervay-Hague J; Saavedra SS
J Am Chem Soc; 2002 Feb; 124(6):968-77. PubMed ID: 11829604
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.
Villard R; Hammache D; Delapierre G; Fotiadu F; Buono G; Fantini J
Chembiochem; 2002 Jun; 3(6):517-25. PubMed ID: 12325007
[TBL] [Abstract][Full Text] [Related]
4. A convenient oxidation of natural glycosphingolipids to their "ceramide acids" for neoglycoconjugation. Bovine serum albumin-glycosylceramide acid conjugates as investigative probes for HIV gp120 coat protein-glycosphingolipid interactions.
Mylvaganam M; Lingwood CA
J Biol Chem; 1999 Jul; 274(29):20725-32. PubMed ID: 10400707
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of biotinylated glycoconjugates and their use in a novel ELISA for direct comparison of HIV-1 Gp120 recognition of GalCer and related carbohydrate analogues.
McReynolds KD; Hadd MJ; Gervay-Hague J
Bioconjug Chem; 1999; 10(6):1021-31. PubMed ID: 10563771
[TBL] [Abstract][Full Text] [Related]
6. A major fraction of glycosphingolipids in model and cellular cholesterol-containing membranes is undetectable by their binding proteins.
Mahfoud R; Manis A; Binnington B; Ackerley C; Lingwood CA
J Biol Chem; 2010 Nov; 285(46):36049-59. PubMed ID: 20716521
[TBL] [Abstract][Full Text] [Related]
7. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
Harrop HA; Rider CC
Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
[TBL] [Abstract][Full Text] [Related]
8. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.
Bhat S; Spitalnik SL; Gonzalez-Scarano F; Silberberg DH
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7131-4. PubMed ID: 1871126
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel glycolipids that bind HIV-1 Gp120.
LaBell RY; Jacobsen NE; Gervay-Hague J; O'Brien DF
Bioconjug Chem; 2002; 13(1):143-9. PubMed ID: 11792190
[TBL] [Abstract][Full Text] [Related]
10. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins.
Liao HX; Alam SM; Mascola JR; Robinson J; Ma B; Montefiori DC; Rhein M; Sutherland LL; Scearce R; Haynes BF
J Virol; 2004 May; 78(10):5270-8. PubMed ID: 15113908
[TBL] [Abstract][Full Text] [Related]
12. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275.
Bhat S; Mettus RV; Reddy EP; Ugen KE; Srikanthan V; Williams WV; Weiner DB
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):175-81. PubMed ID: 8457384
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120.
Kensinger RD; Yowler BC; Benesi AJ; Schengrund CL
Bioconjug Chem; 2004; 15(2):349-58. PubMed ID: 15025531
[TBL] [Abstract][Full Text] [Related]
14. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
[TBL] [Abstract][Full Text] [Related]
15. Density dependent interaction of polymeric analogs of beta-galactosyl ceramide with GP120 of human immunodeficiency virus 1.
Fujita E; Nishimura SI
Carbohydr Lett; 2000; 4(1):53-60. PubMed ID: 11469338
[TBL] [Abstract][Full Text] [Related]
16. Binding of recombinant HIV coat protein gp120 to human monocytes.
Finbloom DS; Hoover DL; Meltzer MS
J Immunol; 1991 Feb; 146(4):1316-21. PubMed ID: 1991970
[TBL] [Abstract][Full Text] [Related]
17. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
Lederman S; Gulick R; Chess L
J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
[TBL] [Abstract][Full Text] [Related]
18. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
Augustin LA; Fantini J; Mootoo DR
Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
Su H; Boackle RJ
Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
[TBL] [Abstract][Full Text] [Related]
20. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
